Dose Optimization of Caffeine for HIE

Dose Optimization of Caffeine for HIE

Conditions: Hypoxic-Ischemic Encephalopathy
Interventions: Drug: Caffeine citrate 20 mg/kg; Drug: Caffeine citrate 30 mg/kg
Sponsors: University of North Carolina, Chapel Hill; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 8, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments